Overcoming aspirin treatment failure in diabetes

Author： Linden Matthew D.   Tran Huyen A.  

Publisher： Informa Healthcare

ISSN： 1040-8363

Source： Critical Reviews in Clinical Laboratory Sciences, Vol.49, Iss.5-6, 2012-12, pp. : 183-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin in the Treatment and Prevention of Cardiovascular Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 3, 2004-11 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 725-734

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of aspirin for prevention and treatment of perioperative cardiovascular events

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S297-S303

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient preferences in diabetes care: overcoming barriers using new strategies

By Desai Jay R   Sperl-Hillen JoAnn M   OConnor Patrick J  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 4, 2013-07 ,pp. : 351-354

Future Medicine

Access to resources Recommend Favorite

Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study

By Hanefeld M.   Pfützner A.   Forst T.   Lübben G.  

Current Medical Research and Opinion, Vol. 22, Iss. 6, 2006-06 ,pp. : 1211-1215

Informa Healthcare

Access to resources Recommend Favorite